INVITED FACULTY
Plenary Session I
-
Cancer Evolution and How Early Intervention May Improve Chance of Cure
Nicholas McGranahan (Univ. College London, UK)
Session I (A) Journey to Make Personalized Medicine More Precise
-
Liquid Biopsy: A Role in Dagnosis and Management of Lung Cancer
Pimpin Incharoen (Mahidol Univ., Thailand)
-
Molecular Biomarker Testing for Non-Small Cell Lung Cancer: Consensus Statement of the Korean Cardiopulmonary Pathology Study Group
Sunhee Chang (Inje Univ.)
-
The Era of Personalized Medicine: How the Pathologist Can Make a Difference?
Philippe Joubert (Laval Univ., Canada)
Satellite Symposium I [ONO/BMS]
-
Recent Update of Checkmate 9LA and Checkmate 227, Pivotal Trials in 1L Non-Small Cell Lung Cancer
Manuel Cobo Dols (Hospital Regional Universitario Málaga, Spain)
Session III (A) Moving Forward with Target Therapy
-
-
-
-
Challenges in the Use of Targeted Therapy in Non-Small Cell Lung Cancer
Alex A. Adjei (Mayo Clinic, USA)
Session IV (A) Advanced Surgical Techniques for Thoracic Malignancies
Satellite Symposium III [MSD]
Session I (B) Updates in Lung Cancer Screening
-
2-Year Experience of National Lung Cancer Screening in Korea
Yeol Kim (National Cancer Center)
-
Lung Cancer Screening with Low-Dose Computed Tomography for Non-Smokers
Pan-Chyr Yang (National Taiwan Univ., Taiwan)
-
Session II (B) Big Data and Registry
-
How to Develop Credible, Useful Real-World Evidence Including Artificial Intelligence and Big Data Analytics
Brian D. Bradbury (Center for Observational Research at Amgen, USA)
-
Way of Real-World Evidence: Past, Present, and Future Opportunities in Korea
Ju-Young Shin (Sungkyunkwan Univ.)
-
-
Satellite Symposium II [Takeda]
-
New Standard of Care in the First-Line Anaplastic Lymphoma Kinase+Non-Small Cell Lung Cancer: Alunbrig ®
Michael Thomas (Universitätsklinikum Heidelberg, Germany)
Session III (B) Korea-Japan Joint Symposium: Multidisciplinary Approach in Early and Locally Advanced Non-Small Cell Lung Cancer
-
Updates of Radiation Therapy in Early Non-Small Cell Lung Cancer
Hitoshi Ishikawa (QST Hospital, Japan)
-
Neo-Adjuvant and Adjuvant Therapy Using Immune Checkpoint Inhibitors
Eun Joo Kang (Korea Univ.)
-
Neo-Adjuvant and Adjuvant Therapy Using Molecular Targeted Therapies
Masahiro Tsuboi (National Cancer Center Hospital East, Japan)
-
Promise and Pitfall in Early Efficacy Evaluation Using Pathologic Response and Minimal Residual Disease
Hyo Sup Shim (Yonsei Univ.)
Session IV (B) Optimizing Radiation Therapy for Lung Cancer
-
Optimal Strategy of Concurrent Chemoradiotherapy for Non-Small Cell Lung Cancer
Si Yeol Song (Univ. of Ulsan)
-
Optimal Dose Fractionation in Small Cell Lung Cancer (Limited Disease and Extensive Disease)
Sung Ho Moon (National Cancer Center)
-
Prophylactic Cranial Irradiation in Lung Cancer
Hideyuki Harada (Shizuoka Cancer Center, Japan)
-